Unitree Robotics just became the first pure-play humanoid robot company to list on China's A-share market, triggering intense debate about whether the valuation reflects genuine industrial progress or inflated expectations. The company's August 10 IPO announcement revealed an extraordinarily competitive subscription rate of just 0.01809759%, meaning fewer than two winners per 10,000 retail investor accounts. This scarcity, combined with projections of potential first-day gains exceeding 200,000 yuan per share, has sparked widespread interest in the humanoid robotics sector as a whole.

Unitree's emergence as a listed company represents a watershed moment for embodied AI investing. For years, capital flowing into robotics had been confined to component makers like harmonic reducers, servo motors, and sensors. Unitree fills a critical void as the first company to scale humanoid robot production to over 5,500 units annually, generate more than 800 million yuan in revenue, and claim the leading position in global shipments. This "first mover" status in the A-share market provides investors with what they've lacked: a standardized instrument for betting on the humanoid robot sector.

What's Driving the Extreme Investor Interest?

The subscription frenzy reflects more than just novelty. Three structural factors converged to create the conditions for Unitree's oversubscribed listing. First, the A-share market has experienced a genuine scarcity of hard technology targets with scalable shipments and proven revenue. Second, Unitree's timing aligns with a critical inflection point in the industry's development cycle. Third, unlike many hard technology debuts, Unitree arrives with solid financial fundamentals rather than pure conceptual narratives.

The company's financial trajectory demonstrates why investors see potential. Unitree generated 1.699 billion yuan in revenue in 2025, with net profit excluding non-recurring items approaching 600 million yuan and a gross margin exceeding 60% for its main business. More striking is the composition of that revenue: humanoid robot sales surged from 2.9671 million yuan in 2023 to 107 million yuan in 2024, then to 868 million yuan in 2025, representing year-on-year growth of 93.12% and 202.60% respectively. By 2025, humanoid robots accounted for 51.78% of the company's main business revenue, up from just 1.88% in 2023.

Why Are Investors Questioning the Valuation?

Despite the strong fundamentals, sharp questions emerged during Unitree's pre-listing roadshow. The core concern centers on sustainability of growth momentum. The company's tenfold revenue increase from 2023 to 2025 anchors its high valuation, but the growth trajectory is already decelerating. For the first half of 2026, Unitree projects revenue between 1.052 billion yuan and 1.128 billion yuan, representing year-on-year growth of only 35.62% to 45.41%. Net profit excluding non-recurring items is expected to decline by approximately 21.97% to 6.43% year-over-year.

The company attributes this slowdown to several factors: a higher revenue base, cooling industry interest, intensifying competition, and increased investment in research and development, talent acquisition, and sales. However, market participants raised a more fundamental question during the roadshow that Unitree did not directly answer: was the explosive growth of the past two years simply a concentrated release of demand from universities and research institutions, a market segment with a distinct ceiling? If research demand saturates and industrial and consumer demand fails to compensate, can the company sustain high growth rates.

How Does Unitree's Business Model Reduce Risk?

One factor distinguishing Unitree from pure-concept robotics plays is its diversified revenue base. The company operates what analysts describe as a "room to run, floor to stand on" business model. Quadruped robot revenue has grown steadily, reaching 120 million yuan in 2023, 230 million in 2024, and 697 million in 2025. This mature business segment provides stable cash flow and fundamental support, even if the high-growth humanoid business lags expectations. This dual-revenue structure aligns with the market's current cautious risk appetite and distinguishes Unitree from competitors relying solely on humanoid robot sales.

• Quadruped Robot Revenue: Provides a stable, growing cash flow foundation that reached 697 million yuan in 2025, offering downside protection if humanoid growth slows.
• Humanoid Robot Scaling: Represents the high-growth opportunity, with revenue accelerating from 2.9671 million yuan in 2023 to 868 million yuan in 2025, capturing emerging industrial and research demand.
• Gross Margin Strength: Main business gross margins exceed 60%, indicating pricing power and operational efficiency that support profitability even during growth transitions.
• Market Leadership Position: Over 5,500 units shipped annually places Unitree ahead of competitors globally, creating network effects and supply chain advantages.

What Does This IPO Mean for the Broader Robotics Sector?

Unitree's listing establishes a critical pricing benchmark for the entire embodied AI sector. Prior to this IPO, humanoid robots existed primarily as concepts in research reports or displays at trade shows. Now, the sector has a tangible market capitalization and performance anchor. This shift from theoretical to priced reflects a broader consensus change in the industry: two years ago, the market debated whether humanoid robots could walk steadily; today, the consensus has shifted to "humanoid robots will be deployed; it is a matter of when".

The issuance structure itself amplified market sentiment. Unitree's total public offering exceeded 40 million shares, but after deducting strategic placements and institutional subscriptions, the free float available to retail investors was limited. Once the clawback mechanism was triggered, the final online tranche was just 9.707 million shares. This scarcity, combined with low subscription thresholds that allowed easy retail participation, created what analysts describe as a "herd effect" where investors sought access to a perceived limited opportunity.

How to Evaluate Humanoid Robot Company Valuations

• Revenue Growth Trajectory: Examine whether growth is accelerating, plateauing, or decelerating year-over-year; Unitree's deceleration from 202% growth to projected 35-45% growth is a key metric to monitor.
• Profit Sustainability: Look beyond revenue to net profit trends; Unitree's projected 21.97% to 6.43% decline in net profit excluding non-recurring items signals margin pressure despite revenue growth.
• Demand Source Composition: Distinguish between research institution demand (which has a ceiling) and industrial or consumer demand (which has longer-term potential); understand whether growth is driven by one-time research purchases or recurring commercial orders.
• Diversified Revenue Base: Assess whether the company relies on a single product line or has multiple revenue streams; Unitree's quadruped business provides stability that pure humanoid-focused competitors lack.
• Competitive Positioning: Verify market share claims and shipment volumes; Unitree's 5,500+ annual units and global leadership position provide defensibility against new entrants.

The fundamental tension underlying Unitree's IPO is whether the company's current valuation reflects reasonable pricing for the start of industrialization or represents an expectation overdraft driven by emotion and scarcity. The company's solid fundamentals, market leadership, and dual-revenue model provide genuine support for a premium valuation. However, the deceleration in growth rates and unanswered questions about demand sustainability suggest that investors should carefully distinguish between the company's near-term performance and its long-term potential before assuming the "first humanoid robot stock" designation guarantees continued outperformance.